Last reviewed · How we verify

high carbohydrate, low glycemic index foods

University of Toronto · Phase 1 active Small molecule Quality 0/100

high carbohydrate, low glycemic index foods is a Small molecule drug developed by University of Toronto. It is currently in Phase 1 development.

At a glance

Generic namehigh carbohydrate, low glycemic index foods
SponsorUniversity of Toronto
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about high carbohydrate, low glycemic index foods

What is high carbohydrate, low glycemic index foods?

high carbohydrate, low glycemic index foods is a Small molecule drug developed by University of Toronto.

Who makes high carbohydrate, low glycemic index foods?

high carbohydrate, low glycemic index foods is developed by University of Toronto (see full University of Toronto pipeline at /company/university-of-toronto).

What development phase is high carbohydrate, low glycemic index foods in?

high carbohydrate, low glycemic index foods is in Phase 1.

Related